Viridian Therapeutics: A Clearer Picture Emerges (Rating Upgrade)

Viridian Therapeutics is a part of the model portfolio of the Biotech Forum. We are currently offering a one-month trial into the Biotech Forum at half the regular price. To see what I and the other season biotech investors are targeting as trading ideas real-time, just join our community at The Biotech Forum by clicking HERE .When I last wrote about Viridian Therapeutics, Inc. ( NASDAQ: VRDN ) in August, I noted this biopharma had some key catalysts up in front of it. One of those catalysts was disclosed M ...